BioSyent
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
12.8511.25
Price/Sales ratio
N/AN/A
Earnings per Share (EPS)
CA$0.56CA$0.64

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
52.1625.7926.6626.9420.5019.4627.0816.6815.7716.5518.9119.46
Price/Sales ratio
13.476.316.416.755.433.974.603.663.083.383.903.97
Price/Book Value ratio
20.167.996.876.314.233.293.833.322.583.073.593.59
Price/Cash Flow ratio
45.2034.5426.1221.4318.6017.8214.9122.4217.4021.1518.6918.60
Price/Free Cash Flow ratio
46.1558.3728.7723.7520.2221.0715.2922.8719.4421.91-1.54K21.07
Price/Earnings Growth ratio
0.811.482.401.342.46-0.94-4.190.23-1.310.720.960.96
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/A0.56%1.78%1.55%N/A
Profitability Indicator Ratios
Gross Profit Margin
78.05%78.69%78.82%76.93%76.99%77.69%78.02%79.10%81.85%81.03%78.73%76.99%
Operating Profit Margin
34.84%32.86%32.10%32.99%31.56%25.14%22.52%28.59%25.00%23.65%23.93%25.14%
Pretax Profit Margin
35.43%33.57%32.75%32.99%35.05%27.40%23.45%29.27%26.60%27.01%27.20%27.40%
Net Profit Margin
25.82%24.46%24.04%25.07%26.50%20.39%16.99%21.94%19.54%20.44%20.59%20.39%
Effective Tax Rate
27.10%27.12%26.58%23.99%24.4%25.57%27.52%25.02%26.54%24.3%24.27%25.57%
Return on Assets
29.62%25.77%22.38%20.73%18.29%14.11%11.30%16.90%13.48%15.55%15.63%14.11%
Return On Equity
38.65%30.98%25.76%23.43%20.66%16.93%14.16%19.90%16.36%18.58%20.01%20.01%
Return on Capital Employed
51.98%41.27%34.06%30.45%24.28%19.51%17.69%24.77%20.08%20.75%21.48%19.51%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A3.91N/A
Quick Ratio
3.644.856.778.338.367.355.397.705.705.413.117.35
Cash ratio
2.831.865.534.835.234.003.944.351.371.441.814.00
Days of Sales Outstanding
19.1532.8539.5340.5835.8635.4929.6631.8141.5740.9746.6635.86
Days of Inventory outstanding
173.21194.26150.0169.28109.31163.40154.19134.53326.68359.03281.49109.31
Operating Cycle
192.36227.12189.54109.86145.18198.90183.86166.35368.25400.01328.15145.18
Days of Payables Outstanding
271.47219.97204.72193.56204.84222.81276.89217.46364.68309.28310.91204.84
Cash Conversion Cycle
-79.117.15-15.18-83.69-59.66-23.90-93.02-51.113.5790.7317.23-59.66
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A134.13N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.301.201.151.131.121.201.251.171.211.191.211.12
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.290.180.240.310.290.220.300.160.170.160.200.22
Free Cash Flow / Operating Cash Flow Ratio
0.970.590.900.900.910.840.970.980.890.96-0.010.84
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/A8.86%29.60%28.68%N/A